V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190007094 | 190004351 | 0 | 51 | Neo-adjuvant (N) | 2014-08-14 | 2016-02-25 | Doxorubicin 75mg/m2 | 02 | N | CARBOPLATIN + GEMCITABINE | 101125341 |
| 190007099 | 190004352 | 1.69 | null | Curative (C) | 2017-08-06 | 2017-08-24 | CAPECITABINE + IRINOTECAN | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101217179 |
| 190007100 | 190004353 | 1.75 | 21.9 | Neo-adjuvant (N) | 2020-07-01 | 2020-07-01 | CYCLOPHOSPHAMIDE | 02 | Y | CARBOPLATIN + GEMCITABINE | 101055991 |
| 190007102 | 190004354 | 1.43 | 79.5 | Palliative (P) | 2017-05-08 | 2017-06-13 | OST Euramos 1 Closed Trial - IE | 02 | null | TRIAL UNSPECIFIED | 100863813 |
| 190007104 | 190004355 | 0 | 36 | Adjuvant (A) | 2019-01-22 | 2019-09-09 | EW EuroEwing 2012 Arm A VAI | 02 | null | CARBOPLATIN + GEMCITABINE | 100313038 |
| 190007105 | 190004356 | 1.58 | 120 | Palliative (P) | 2020-05-17 | 2020-05-26 | CARBOPLATIN | 02 | null | CISPLATIN + FLUOROURACIL | 101384034 |
| 190007109 | 190004357 | 1.77 | 75.3 | Curative (C) | 2017-10-12 | 2018-06-02 | CARBOPLATIN + ETOPOSIDE | 01 | Y | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 101866525 |
| 190007113 | 190004358 | 1.6 | 92.1 | Curative (C) | 2018-01-27 | 2018-02-11 | CAPECITABINE + TEMOZOLOMIDE | 02 | Y | FLUOROURACIL + IRINOTECAN | 101195531 |
| 190007117 | 190004359 | 1.6 | 72 | null | 2018-05-02 | 2018-05-02 | Capecitabine + Oxaliplatin 21day | N | N | CETUXIMAB | 101406096 |
| 190007127 | 190004360 | 1.75 | 58.3 | Neo-adjuvant (N) | 2017-11-23 | 2017-12-01 | Ifosfamide | 02 | N | BEVACIZUMAB | 100789348 |
| 190007136 | 190004361 | null | 82 | null | 2019-07-22 | 2019-07-24 | IMATINIB | 02 | N | PACLITAXEL | 100178389 |
| 190007141 | 190004362 | null | 53.6 | null | 2016-03-31 | 2016-06-14 | Cisplatin + Etoposide po&iv 3 day | 01 | N | CISPLATIN + RT | 101036834 |
| 190007146 | 190004363 | 1.61 | 63.1 | Palliative (P) | 2016-03-13 | 2016-03-13 | Carboplatin + Etoposide IV 3 day | 02 | null | CARBOPLATIN + ETOPOSIDE | 100449157 |
| 190007151 | 190004364 | 1.64 | 51 | null | 2021-02-25 | 2021-02-25 | CARBOPLATIN | N | N | CARBOPLATIN | 101632479 |
| 190007156 | 190004365 | 1.51 | 63.45 | null | 2019-02-27 | 2019-02-28 | Irinotecan + Temozolomide | 02 | N | CAPECITABINE + GEMCITABINE | 101193618 |
| 190007158 | 190004366 | 1.69 | 60.58 | Neo-adjuvant (N) | 2021-01-11 | 2021-02-06 | EURAMOS TRIAL | 02 | N | PACLITAXEL | 100600344 |
| 190007159 | 190004367 | null | null | 03 | 2020-01-28 | 2020-01-28 | CAPECITABINE + TEMOZOLOMIDE | 01 | null | CARBOPLATIN + GEMCITABINE | 100187295 |
| 190007163 | 190004369 | 0 | 77 | Curative (C) | 2019-04-15 | 2019-05-17 | OST Euramos 1 Closed Trial - M | Y | N | CAPECITABINE | 101415502 |
| 190007166 | 190004370 | 1.8 | 76.8 | null | 2017-07-07 | 2017-11-28 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | 02 | null | GEMCITABINE | 100421778 |
| 190007179 | 190004371 | 0 | 26 | null | 2016-05-03 | 2016-05-05 | EW EuroEwing 2012 Arm A/B BuMEL | 02 | N | GEMCITABINE | 100064274 |
| 190007183 | 190004372 | 1.27 | 43.3 | Palliative (P) | null | 2019-09-23 | Atezolizumab | 02 | null | PACLITAXEL | 101677202 |
| 190007184 | 190004373 | 0 | 46 | null | null | 2021-09-19 | CARBOPLATIN + RT | 02 | null | CARBOPLATIN | 101748547 |
| 190007190 | 190004374 | null | 27 | Adjuvant (A) | 2018-10-16 | 2018-11-02 | EW Rel rEECur Irinotecan/Temozolomide | 02 | null | CAPECITABINE | 101819384 |
| 190007192 | 190004375 | 0 | 63.4 | null | 2019-04-09 | 2019-08-29 | ECX | 02 | N | FLUOROURACIL + IRINOTECAN | 100554476 |
| 190007198 | 190004376 | 1.8 | 58.5 | Palliative (P) | 2019-06-22 | 2019-06-27 | CARBOPLATIN | 01 | N | CARBOPLATIN | 100482513 |
| 190007201 | 190004377 | null | 95.9 | null | 2016-06-24 | 2016-07-15 | Azacitidine | 02 | null | FLUOROURACIL + IRINOTECAN | 101212854 |
| 190007209 | 190004378 | 1.69 | 88.9 | null | null | 2017-08-25 | Doxorubicin + Ifosfamide | 02 | null | CARBOPLATIN + THIOTEPA + TOPOTECAN | 101138951 |
| 190007216 | 190004379 | 1.53 | 65.2 | Palliative (P) | 2016-11-14 | 2017-04-22 | Cisplatin | 02 | N | CISPLATIN | 100127293 |
| 190007222 | 190004380 | 0 | 19.2 | null | 2016-12-30 | 2017-01-20 | Irinotecan + Modified De Gramont | 02 | N | NIVOLUMAB | 100820915 |
| 190007224 | 190004381 | 0 | 23.6 | Neo-adjuvant (N) | 2016-09-03 | 2016-09-09 | EW EuroEwing 2012 Arm A VAI | 02 | Y | CAPECITABINE + IRINOTECAN | 101541594 |
| 190007228 | 190004382 | 1.66 | 59.3 | null | 2017-08-25 | 2017-09-01 | EW Rel rEECur Gemcitabine/Docetaxel | 01 | N | CARBOPLATIN + ETOPOSIDE | 101566965 |
| 190007240 | 190004383 | 0 | 54 | Curative (C) | null | 2019-10-06 | EW EuroEwing 99 : VIDE | 01 | null | FLUOROURACIL + OXALIPLATIN | 101621871 |
| 190007241 | 190004384 | 1.72 | 80 | Adjuvant (A) | null | 2019-06-01 | CARBOPLATIN + ETOPOSIDE | 02 | null | FULVESTRANT + PALBOCICLIB | 101430309 |
| 190007243 | 190004385 | 1.68 | 75.6 | Curative (C) | null | 2017-09-29 | EURAMOS TRIAL | null | null | CARBOPLATIN + ETOPOSIDE | 100539888 |
| 190007244 | 190004386 | 1.73 | 90 | null | 2021-03-26 | 2021-06-28 | OCTREOTIDE | 02 | null | CAPECITABINE + GEMCITABINE | 100052913 |
| 190007250 | 190004387 | 1.72 | 89 | null | 2020-01-05 | 2020-01-11 | Cisplatin | null | null | CISPLATIN | 100855440 |
| 190007251 | 190004388 | 1.74 | 93 | Curative (C) | 2019-11-23 | 2019-11-29 | NIVOLUMAB | null | Y | LIPOSOMAL DOXORUBICIN | 100144544 |
| 190007253 | 190004389 | 1.77 | 67.6 | Palliative (P) | 2018-01-12 | 2018-01-13 | EW EuroEwing 2012 Arm A VAI | 02 | null | CAPECITABINE | 100199621 |
| 190007255 | 190004390 | 1.78 | 77.9 | Curative (C) | 2017-10-02 | 2017-10-04 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | TEMOZOLOMIDE | 100201990 |
| 190007260 | 190004391 | 1.66 | 113.5 | Curative (C) | 2016-06-29 | 2017-04-27 | Fulvestrant + Ribociclib | 02 | null | LANREOTIDE | 100943121 |
| 190007261 | 190004392 | 1.7 | 33.5 | Palliative (P) | 2017-07-01 | 2019-04-26 | DHAP | 02 | N | GEMCITABINE | 101046069 |
| 190007270 | 190004393 | 1.62 | 59 | Neo-adjuvant (N) | 2021-08-29 | 2021-09-05 | CAPECITABINE + CARBOPLATIN | 01 | N | PACLITAXEL | 100147824 |
| 190007274 | 190004394 | 1.75 | 60 | Neo-adjuvant (N) | 2017-11-08 | 2017-11-13 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101239029 |
| 190007275 | 190004395 | 1.75 | 86.8 | Curative (C) | 2019-08-12 | 2019-08-26 | Gemcitabine day 1&8 | 01 | N | FLUOROURACIL + OXALIPLATIN | 100607781 |
| 190007279 | 190004396 | 1.9 | 59 | null | 2019-01-25 | 2019-01-25 | CARBOPLATIN + PACLITAXEL | Y | N | CARBOPLATIN + PACLITAXEL | 100632624 |
| 190007286 | 190004397 | 1.66 | 64.1 | Neo-adjuvant (N) | 2016-05-22 | 2016-06-10 | VAI (Ifos 3g/m2) | N | N | RIBOCICLIB | 100927376 |
| 190007289 | 190004398 | 1.8 | 75.2 | Palliative (P) | null | 2017-05-20 | Cisplatin 7 day | null | null | CISPLATIN | 100323555 |
| 190007298 | 190004399 | 1.61 | 58 | Curative (C) | 2018-12-23 | 2019-02-25 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | FLUOROURACIL + IRINOTECAN | 100588413 |
| 190007300 | 190004400 | 0 | 20.5 | null | 2019-06-07 | 2019-06-18 | OST Rel Ifosfamide Etoposide Mtx | 01 | N | CARBOPLATIN + FLUOROURACIL | 101064776 |
| 190007301 | 190004401 | 1.78 | 10.4 | Palliative (P) | 2021-08-09 | 2021-08-11 | CISPLATIN + GEMCITABINE | 02 | null | NIVOLUMAB | 101154955 |